Related Experiment Video
Updated: Apr 19, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
Meeting report VLPNPV: Session 3: Immune responses
1a Department of Microbiology and Physiological Systems ; University of Massachusetts Medical School ; Worcester , MA USA.
Virus-like particles (VLPs) and nanoparticles (NPs) show promise as vaccines for diseases. Research is advancing VLP and NP development, characterization, production, and immune responses for future applications.
Area of Science:
- Biotechnology
- Immunology
- Vaccinology
Background:
- Virus-like particles (VLPs) and nanoparticles (NPs) are gaining traction as vaccine candidates for various diseases.
- Two VLPs, the human papillomavirus and hepatitis B vaccines, are already licensed for human use.
- An international conference in 2014 highlighted the growing interest and research in VLPs and NPs.
More Related Videos
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...